Status:
COMPLETED
Community-engaged Approaches to Testing in Community and Healthcare Settings for Underserved Populations
Lead Sponsor:
University of Oklahoma
Collaborating Sponsors:
National Institutes of Health (NIH)
National Institute of General Medical Sciences (NIGMS)
Conditions:
Covid19
Eligibility:
All Genders
Phase:
NA
Brief Summary
The pandemic caused by the novel coronavirus, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), has resulted in substantial global morbidity and mortality including in Oklahoma and caused ...
Detailed Description
The broad RADx-UP initiative aims to understand the factors associated with COVID-19 morbidity and mortality disparities and to lay the foundation to reduce disparities for underserved and vulnerable ...
Eligibility Criteria
Inclusion
- Practices:
- Primary care practices located in Oklahoma.
- Priority to practices serving a majority of patients that are underserved or vulnerable populations (rural, minority, elderly).
- Practices routinely using a certified electronic health record (EHR) will be eligible to participate, as practices that are still using paper records are either planning to close due to clinician retirement or will likely be implementing an EHR during the project, which would compromise their ability to participate.
- Practice-wide participation will be encouraged, but participation of all members within a practice (both clinicians and staff members) will not be required. The minimum acceptable level of participation will be one clinician and nurse/medical assistant dyad plus anyone else who would have to be involved to make changes in the processes of care (e.g. clinic manager) for that unit of care.
- Clinicians and staff members 18 years of age and older at the time of enrollment (consent).
- Patients survey participants:
- Patients (or caregivers of patients) who are seen in eligible practices or community testing sites and received a recommendation for the patient to receive a SARS-CoV-2 diagnostic test.
- Patients (or their caregivers) who are 18 or older
Exclusion
- Practices:
- Practices that are uninterested in reducing missed opportunities for guidelines-based testing for SARS-CoV-2
- Solo practices with a clinician planning to retire within 12 months of enrollment will not be eligible for participation.
- Practices likely to experience ownership change in the next 12 months will not be eligible for participation.
- Patient survey participants:
- Patients unable to complete the consent process or survey instruments in English or Spanish.
- Patients or caregivers of patients who are under the age of 18.
Key Trial Info
Start Date :
September 30 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 30 2023
Estimated Enrollment :
323 Patients enrolled
Trial Details
Trial ID
NCT04870307
Start Date
September 30 2020
End Date
June 30 2023
Last Update
January 30 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Oklahoma Clinical and Translational Science Institute
Oklahoma City, Oklahoma, United States, 73104